Status
Conditions
Treatments
About
The project will consist of a multicentre, prospective, observational study with a total duration of 24 months. Clinical, endoscopic and ultrasound data will be collected in a dedicated database (on IG-IBD Register), which will be used to identify potential clinical, endoscopic and ultrasound risk factors of re-operation. These data could be merged into a shared score, to stratify patients according to the risk of post-surgical re- operation and to define an optimal therapeutic management in the post- operative period. Approximately 220 adult patients, with a defined diagnosis of CD, who underwent a surgery for CD in the previous 6 months will be enrolled.
Full description
Patients will be consecutively enrolled in this prospective cross-sectional study, during the first 12 months, and then followed for 12 (minimum) up to 24(maximum) months, depending on date of patients' enrolment (total study length: 2 years). Patients will be stratified according to risk factors and type of treatment carried out in that year
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
220 participants in 1 patient group
Loading...
Central trial contact
Silvio Danese, MD, PhD; Federica Furfaro, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal